DPP-4 inhibition with linagliptin ameliorates cognitive impairment and brain atrophy induced by transient cerebral ischemia in type 2 diabetic mice

BACKGROUND: It is unclear whether dipeptidylpeptidase-4 (DPP-4) inhibition can counteract the impairment of cognitive function and brain injury caused by transient cerebral ischemia in type 2 diabetes. The present study was undertaken to test our hypothesis that linagliptin, a DPP-4 inhibitor, admin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, MingJie, Hasegawa, Yu, Koibuchi, Nobutaka, Toyama, Kensuke, Uekawa, Ken, Nakagawa, Takashi, Lin, Bowen, Kim-Mitsuyama, Shokei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458052/
https://www.ncbi.nlm.nih.gov/pubmed/25986579
http://dx.doi.org/10.1186/s12933-015-0218-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458052/
https://www.ncbi.nlm.nih.gov/pubmed/25986579
http://dx.doi.org/10.1186/s12933-015-0218-z

Ejemplares similares